Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion type Assertion NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_head.
- NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_provenance.
- NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion evidence source_evidence_literature NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_provenance.
- NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion SIO_000772 21397974 NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_provenance.
- NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion wasDerivedFrom befree-20140225 NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_provenance.
- NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_assertion wasGeneratedBy ECO_0000203 NP649501.RAVvyaeatoAUB1acWqKY-tPer3U7jNEr1uGPN-S4E3MxM130_provenance.